Zydus Lifesciences has secured USFDA approval to market Diltiazem Hydrochloride tablets, used for treating angina and high blood pressure, ...

When it is Trump, logic usually flies out of the window. There is, indeed, little that is logical about the reciprocal tariffs he has annou...

Aurobindo, Glenmark, and Zydus are recalling pharmaceutical products in the US due to manufacturing issues. Aurobindo and Glenmark's recall...

Alembic Pharmaceuticals Ltd has secured final approval from the USFDA for its generic Diltiazem Hydrochloride extended-release capsules. Th...

Alembic Pharmaceuticals has received USFDA final approval for its generic Diltiazem Hydrochloride extended-release capsules in strengths of...

The private sector lender reported Q2 profit growth of 5% year-on-year (YoY) to Rs 16,821 crore, which was above Street estimates.

As per the USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporar...

While they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...

Princeton (New Jersey) based Sun Pharmaceutical Inc is recalling the affected lot due to "Failed Impurity (Deacetyl Diltiazem Hydrochloride...

Drug firm Glenmark Pharmaceuticals on Tuesday said it has received approval from the US health regulator for its generic Diltiazem Hydrochl...

With the latest approvals from the USFDA, the group now has more than 140 approvals and has so far filed over 300 abbreviated new drug appl...

Sun Pharma has received approval from USFDA for its abbreviated new drug application to market a generic version of Schering Plough's Clari...